Elebrato Ellipta European Union - English - EMA (European Medicines Agency)

elebrato ellipta

glaxosmithkline trading services limited - fluticasone furoate, umeclidinium bromide, vilanterol trifenatate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - elebrato ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.

Trelegy Ellipta European Union - English - EMA (European Medicines Agency)

trelegy ellipta

glaxosmithkline trading services - fluticasone furoate, umeclidinium bromide, vilanterol trifenatate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - trelegy ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.

Avamys European Union - English - EMA (European Medicines Agency)

avamys

glaxosmithkline (ireland) limited - fluticasone furoate - rhinitis, allergic, seasonal; rhinitis, allergic, perennial - nasal preparations, corticosteroids - adults, adolescents (12 years and over) and children (6-11 years). avamys is indicated for the treatment of the symptoms of allergic rhinitis.

Arnuity Ellipta New Zealand - English - Medsafe (Medicines Safety Authority)

arnuity ellipta

glaxosmithkline nz limited - fluticasone furoate 100ug;   - powder for inhalation - 100 mcg - active: fluticasone furoate 100ug   excipient: lactose monohydrate - indicated for maintenance treatment of asthma in patients aged not less than 12 years

Arnuity Ellipta New Zealand - English - Medsafe (Medicines Safety Authority)

arnuity ellipta

glaxosmithkline nz limited - fluticasone furoate 200ug;   - powder for inhalation - 200 mcg - active: fluticasone furoate 200ug   excipient: lactose monohydrate - indicated for maintenance treatment of asthma in patients aged not less than 12 years

BREO ELLIPTA fluticasone furoate and vilanterol trifenatate powder United States - English - NLM (National Library of Medicine)

breo ellipta fluticasone furoate and vilanterol trifenatate powder

glaxo operations uk ltd - fluticasone furoate (unii: js86977wnv) (fluticasone - unii:cut2w21n7u) - fluticasone furoate 100 ug

FLUTICASONE PROPIONATE spray, metered United States - English - NLM (National Library of Medicine)

fluticasone propionate spray, metered

hikma pharmaceuticals usa inc. - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 50 ug - fluticasone propionate nasal spray is indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adults and pediatric patients aged 4 years and older. fluticasone propionate nasal spray is contraindicated in patients with hypersensitivity to any of its ingredients [see warnings and precautions (5.3) , description (11)] . risk summary there are insufficient data on the use of fluticasone propionate nasal spray in pregnant women to inform a drug-associated risk. in animals, teratogenicity characteristic of corticosteroids, decreased fetal body weight and/or skeletal variations, were observed in rats, mice, and rabbits with subcutaneously administered maternal toxic doses of fluticasone propionate 5 times, equivalent to, and less than the maximum recommended human daily intranasal dose (mrhdid) on a mcg/m2 basis, respectively. (see animal data. ) however, fluticasone propionate administered via nose-only inhalation to rats decreased fetal body weight, but did not induce teratogenici